2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

Summary by AI BETAClose X

Novonesis announced its 'GROW' strategy with 2030 targets including an organic sales CAGR of 6-9%, an adjusted EBITDA margin of approximately 39%, and an adjusted ROIC excluding goodwill of approximately 16%. The organic sales growth will be driven primarily by volume, including synergies, and a 1-2% annual price contribution. The company plans a net debt/EBITDA ratio of around 1.5x and a dividend payout ratio of 40-60% of adjusted net profit. Capital expenditure (CAPEX) as a percentage of sales will be high initially, gradually decreasing to the high single digits by the end of the strategy period. The 2030 targets assume constant currencies and no major economic disruptions.

Disclaimer*

UK 100

Latest directors dealings